Correspondence on 'Cardiovascular toxicities associated with bispecific T-cell engager therapy Response

被引：1
|
作者：
Sayed, Ahmed [1 ]
Munir, Malak [1 ]
Poliner, Michael [2 ]
Sughra, Sana [2 ]
Epperla, Narendranath [3 ]
Addison, Daniel [4 ,5 ]
机构：
[1] Ain Shams Univ, Fac Med, Cairo, Egypt
[2] Ohio State Univ, Med Ctr, Columbus, OH USA
[3] Ohio State Univ, Columbus, OH USA
[4] Ohio State Univ, Cardiooncol Program, Div Cardiol, Med Ctr, Columbus, OH USA
[5] Ohio State Univ, James Canc Hosp, Div Canc Control & Prevent, Columbus, OH 43210 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2024年 / 12卷 / 04期
关键词：
T cell; ONCOLOGY; FOOD;
D O I：
10.1136/jitc-2024-009300
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Correspondence on 'Cardiovascular toxicities associated with bispecific T-cell engager therapy
    Noguchi, Yoshihiro
    Yan, Miao
    Tachi, Tomoya
    Yoshimura, Tomoaki
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (04)
  • [2] Cardiovascular toxicities associated with bispecific T-cell engager therapy
    Sayed, Ahmed
    Munir, Malak
    Ghazi, Sanam M.
    Ferdousi, Mussammat
    Krishan, Satyam
    Shaaban, Adnan
    Habib, Alma
    Kola-Kehinde, Onaopepo
    Ruz, Patrick
    Khan, Sarah
    Sharma, Sneha
    Meara, Alexa
    Mahmood, Syed
    Feldman, Stephanie
    Yang, Eric H.
    Kim, Jiwon
    Epperla, Narendranath
    Addison, Daniel
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (02)
  • [3] Cardiovascular Toxicities Associated with Bispecific T-Cell Engagers
    Sayed, Ahmed
    Munir, Malak
    Ghazi, Sanam
    Ferdousi, Mussammat
    Krishan, Satyam
    Shaaban, Adnan
    Habib, Alma
    Kola-Kehinde, Onaopepo
    Ruz, Patrick
    Khan, Sarah
    Sharma, Sneha
    Mera, Alexa
    Epperla, Narendranath
    Addison, Daniel
    BLOOD, 2023, 142
  • [4] Safety of Bispecific T-cell Engager Therapy in Autoimmune Disease
    Hagen, Melanie
    Bucci, Laura
    Boeltz, Sebastian
    Noethling, Danae-Mona
    Rothe, Tobias
    Raimondo, Maria Gabriella
    Tur, Carlo
    Wirsching, Andreas
    Wacker, Jochen
    Bozec, Aline
    Schett, Georg
    Grieshaber-Bouyer, Ricardo
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2299 - 2300
  • [5] T-cell Immunotherapy and Cardiovascular Disease Chimeric Antigen Receptor T-cell and Bispecific T-cell Engager Therapies
    Stein-Merlob, Ashley F.
    Ganatra, Sarju
    Yang, Eric H.
    HEART FAILURE CLINICS, 2022, 18 (03) : 443 - 454
  • [6] Mechanisms of resistance to bispecific T-cell engager therapy for ovarian cancer
    Barakzai, Syem
    Xu, Mengyao
    Veillard, Irva
    Matoba, Yusuke
    Kononenko, Artem
    Kim, Eugene
    Bregar, Amy
    Eisenhauer, Eric L.
    Penson, Richard T.
    Bouberhan, Sara
    Colella, Tina
    Clark, Caroline
    Castro, Cesar Martin
    Spriggs, David R.
    Rueda, Bo R.
    Yeku, Oladapo O.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Perils and Problems in Bispecific T-Cell Engager Antibodies
    Khushboo, Bisht
    Kumar, Joshi Rajat
    CURRENT DRUG SAFETY, 2024,
  • [8] Cardiovascular Toxicities of CAR T-cell Therapy
    Nikita P. Patel
    Peter G. Doukas
    Leo I. Gordon
    Nausheen Akhter
    Current Oncology Reports, 2021, 23
  • [9] Cardiovascular Toxicities of CAR T-cell Therapy
    Patel, Nikita P.
    Doukas, Peter G.
    Gordon, Leo, I
    Akhter, Nausheen
    CURRENT ONCOLOGY REPORTS, 2021, 23 (07)
  • [10] Cardiotoxicities of Novel Therapies in Hematologic Malignancies: Chimeric Antigen Receptor T-Cell Therapy and Bispecific T-Cell Engager Therapy
    Marar, Rosalyn I. I.
    Abbasi, Muhannad Aboud
    Prathivadhi-Bhayankaram, Sruti
    Daryanani, Andres
    Villarraga, Hector
    Anavekar, Nandan
    Bhatt, Vijaya Raj
    Paludo, Jonas
    JCO ONCOLOGY PRACTICE, 2023, 19 (06) : 331 - +
12345